These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 17148659)

  • 21. Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition.
    Biolo A; Ramamurthy S; Connors LH; O'Hara CJ; Meier-Ewert HK; Soo Hoo PT; Sawyer DB; Seldin DC; Sam F
    Circ Heart Fail; 2008 Nov; 1(4):249-57. PubMed ID: 19808299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thermal stability threshold for amyloid formation in light chain amyloidosis.
    Poshusta TL; Katoh N; Gertz MA; Dispenzieri A; Ramirez-Alvarado M
    Int J Mol Sci; 2013 Nov; 14(11):22604-17. PubMed ID: 24248061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects on light chain amyloid formation depend on mutations and type of glycosaminoglycans.
    Blancas-Mejía LM; Hammernik J; Marin-Argany M; Ramirez-Alvarado M
    J Biol Chem; 2015 Feb; 290(8):4953-4965. PubMed ID: 25538238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of amyloid fibril formation by two closely related immunoglobulin light chain variable domains.
    Martin DJ; Ramirez-Alvarado M
    Amyloid; 2010 Sep; 17(3-4):129-36. PubMed ID: 21077798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Doxycycline reduces fibril formation in a transgenic mouse model of AL amyloidosis.
    Ward JE; Ren R; Toraldo G; Soohoo P; Guan J; O'Hara C; Jasuja R; Trinkaus-Randall V; Liao R; Connors LH; Seldin DC
    Blood; 2011 Dec; 118(25):6610-7. PubMed ID: 21998211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic amyloidoses.
    Blancas-Mejía LM; Ramirez-Alvarado M
    Annu Rev Biochem; 2013; 82():745-74. PubMed ID: 23451869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AL-amyloidosis and light-chain deposition disease light chains induce divergent phenotypic transformations of human mesangial cells.
    Keeling J; Teng J; Herrera GA
    Lab Invest; 2004 Oct; 84(10):1322-38. PubMed ID: 15286662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain-mediated cardiotoxicity.
    Guan J; Mishra S; Qiu Y; Shi J; Trudeau K; Las G; Liesa M; Shirihai OS; Connors LH; Seldin DC; Falk RH; MacRae CA; Liao R
    EMBO Mol Med; 2014 Nov; 6(11):1493-507. PubMed ID: 25319546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Light chain amyloidosis: Where are the light chains from and how they play their pathogenic role?
    Zhang C; Huang X; Li J
    Blood Rev; 2017 Jul; 31(4):261-270. PubMed ID: 28336182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In situ characterization of protein aggregates in human tissues affected by light chain amyloidosis: a FTIR microspectroscopy study.
    Ami D; Lavatelli F; Rognoni P; Palladini G; Raimondi S; Giorgetti S; Monti L; Doglia SM; Natalello A; Merlini G
    Sci Rep; 2016 Jul; 6():29096. PubMed ID: 27373200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Kinetic Stability of a Full-Length Antibody Light Chain Dimer Determines whether Endoproteolysis Can Release Amyloidogenic Variable Domains.
    Morgan GJ; Kelly JW
    J Mol Biol; 2016 Oct; 428(21):4280-4297. PubMed ID: 27569045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toward understanding the molecular pathogenesis of monoclonal immunoglobulin light-chain deposition.
    Bellotti V; Merlini G
    Nephrol Dial Transplant; 1996 Sep; 11(9):1708-11. PubMed ID: 8918605
    [No Abstract]   [Full Text] [Related]  

  • 33. 2A4 binds soluble and insoluble light chain aggregates from AL amyloidosis patients and promotes clearance of amyloid deposits by phagocytosis
    Renz M; Torres R; Dolan PJ; Tam SJ; Tapia JR; Li L; Salmans JR; Barbour RM; Shughrue PJ; Nijjar T; Schenk D; Kinney GG; Zago W
    Amyloid; 2016 Sep; 23(3):168-177. PubMed ID: 27494229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.
    Gertz MA; Comenzo R; Falk RH; Fermand JP; Hazenberg BP; Hawkins PN; Merlini G; Moreau P; Ronco P; Sanchorawala V; Sezer O; Solomon A; Grateau G
    Am J Hematol; 2005 Aug; 79(4):319-28. PubMed ID: 16044444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amyloid in endomyocardial biopsies.
    Kieninger B; Eriksson M; Kandolf R; Schnabel PA; Schönland S; Kristen AV; Hegenbart U; Lohse P; Röcken C
    Virchows Arch; 2010 May; 456(5):523-32. PubMed ID: 20376481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic AL (light-chain) amyloidosis and the gastrointestinal tract.
    Sattianayagam P; Gibbs S; Hawkins P; Gillmore J
    Scand J Gastroenterol; 2009; 44(11):1384-5. PubMed ID: 19891590
    [No Abstract]   [Full Text] [Related]  

  • 37. An animal model of glomerular light-chain-associated amyloidogenesis depicts the crucial role of lysosomes.
    Teng J; Turbat-Herrera EA; Herrera GA
    Kidney Int; 2014 Oct; 86(4):738-46. PubMed ID: 24786709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytotoxicity of amyloidogenic immunoglobulin light chains in cell culture.
    Sikkink LA; Ramirez-Alvarado M
    Cell Death Dis; 2010 Nov; 1(11):e98. PubMed ID: 21368874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aggregation of Full-length Immunoglobulin Light Chains from Systemic Light Chain Amyloidosis (AL) Patients Is Remodeled by Epigallocatechin-3-gallate.
    Andrich K; Hegenbart U; Kimmich C; Kedia N; Bergen HR; Schönland S; Wanker E; Bieschke J
    J Biol Chem; 2017 Feb; 292(6):2328-2344. PubMed ID: 28031465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amyloidogenic light chains impair plasma cell survival.
    Pick M; Lebel E; Elgavish S; Benyamini H; Nevo Y; Hertz R; Bar-Tana J; Rognoni P; Merlini G; Gatt ME
    Haematologica; 2023 Dec; 108(12):3359-3371. PubMed ID: 37381778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.